{"pmid":32266694,"title":"Chloroquine for COVID-19 Infection.","text":["Chloroquine for COVID-19 Infection.","Drug Saf","Moore, Nicholas","32266694"],"journal":"Drug Saf","authors":["Moore, Nicholas"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32266694","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s40264-020-00933-4","source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Chloroquine"],"_version_":1663609715772358657,"score":7.9164424,"similar":[{"pmid":32147496,"title":"Of chloroquine and COVID-19.","text":["Of chloroquine and COVID-19.","Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.","Antiviral Res","Touret, Franck","de Lamballerie, Xavier","32147496"],"abstract":["Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research."],"journal":"Antiviral Res","authors":["Touret, Franck","de Lamballerie, Xavier"],"date":"2020-03-10T11:00:00Z","year":2020,"_id":"32147496","week":"202011|Mar 09 - Mar 15","doi":"10.1016/j.antiviral.2020.104762","keywords":["2019-nCoV","Antiviral","COVID-19","Chloroquine","SARS-CoV-2"],"source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Chloroquine"],"_version_":1663352134145409025,"score":41.969612}]}